In the pharmaceutical industry, it is a standard practice to screen new candidate drugs, but at the same time, requirements on instrumentation and assays are ever increasing. Especially, as there is a ...
At the 6th Cisbio HTRF symposium, “Charting the Course of Drug Discovery,” held recently in Brewster, MA, investigators described how homogeneous time-resolved fluorescence (HTRF ®) continues to ...
The HTRF technology invented by French company Cisbio has been developed further to provide kits, reagents and services for drug discovery research. In life science, the company’s homogeneous assays ...
Sensitivity of Fluorescence Coupled to Low Background of Time Resolution At the 6 th Cisbio HTRF symposium, “Charting the Course of Drug Discovery” held recently in Brewster, MA, investigators ...
Based on Cisbio Bioassays' patented HTRF® technology, HTRF Transcreener® ADP assay is a universal method for identifying and characterizing the phosphotransferase activity of ATPases and kinases. ADP ...
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., a ...
Related to important targets in the fields of inflammation and metabolic diseases, the assays for cGMP, PGE2, and cortisol constitute the third product line in Cisbio’s portfolio and integrate its ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results